Yuji Aoki (2016) “Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics”, Diabetes Research, 2(2), pp. 45–49. doi: 10.17140/DROJ-2-128.